Atlas Trials

Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

Clinical trial NCT01535885 · COMPLETED

Trial details

NCT number
NCT01535885
Sponsor
Medical College of Wisconsin
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epstein-Barr Virus InfectionsAdenovirusCytomegalovirus Infections
Start date
2012-02-01
Primary completion
2019-10-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.